LXRX
Lexicon Pharmaceuticals Inc
Price:  
1.64 
USD
Volume:  
1,786,193.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX WACC - Weighted Average Cost of Capital

The WACC of Lexicon Pharmaceuticals Inc (LXRX) is 8.1%.

The Cost of Equity of Lexicon Pharmaceuticals Inc (LXRX) is 8.55%.
The Cost of Debt of Lexicon Pharmaceuticals Inc (LXRX) is 7.00%.

Range Selected
Cost of equity 6.80% - 10.30% 8.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.5% - 9.6% 8.1%
WACC

LXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 10.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.17 0.17
Cost of debt 7.00% 7.00%
After-tax WACC 6.5% 9.6%
Selected WACC 8.1%